CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy (vol 139, pg 95, 2013)

被引：0
|
作者：
Teft, Wendy A. [1 ]
Gong, Inna Y. [1 ,2 ]
Dingle, Brian [3 ]
Potvin, Kylea [3 ]
Younus, Jawaid [3 ]
Vandenberg, Theodore A. [3 ]
Brackstone, Muriel [3 ,4 ]
Perera, Francisco E. [3 ]
Choi, Yun-Hee [5 ]
Zou, Guangyong [5 ]
Legan, Robin M. [1 ]
Tirona, Rommel G. [1 ,2 ]
Kim, Richard B. [1 ,2 ,3 ,6 ]
机构：
[1] Univ Western Ontario, Dept Med, Div Clin Pharmacol, London, ON, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London, ON, Canada
[4] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada
[5] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[6] LHSC Univ Hosp, Dept Med, London, ON N6A 5A5, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2013年 / 142卷 / 01期
关键词：
D O I：
10.1007/s10549-013-2706-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [21] Constituents of Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activity
    Subehan
    Usia, T
    Kadota, S
    Tezuka, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2005, 53 (03) : 333 - 335
  • [22] Probabilistic Prediction of the Human CYP3A4 and CYP2D6 Metabolism Sites
    Dapkunas, Justas
    Sazonovasay, Andrius
    Japertas, Pranas
    CHEMISTRY & BIODIVERSITY, 2009, 6 (11) : 2101 - 2106
  • [23] CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy
    Jansen, Laura E.
    Teft, Wendy A.
    Rose, Rhiannon V.
    Lizotte, Daniel J.
    Kim, Richard B.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 701 - 708
  • [24] Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen
    ter Heine, Rob
    Binkhorst, Lisette
    de Graan, Anne Joy M.
    de Bruijn, Peter
    Beijnen, Jos H.
    Mathijssen, Ron H. J.
    Huitema, Alwin D. R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 572 - 586
  • [25] CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy
    Laura E. Jansen
    Wendy A. Teft
    Rhiannon V. Rose
    Daniel J. Lizotte
    Richard B. Kim
    Breast Cancer Research and Treatment, 2018, 171 : 701 - 708
  • [26] VARIATION IN THE IN VITRO INHIBITION OF CYP3A4, CYP2D6 AND CYP1A2 BY DIFFERENT COMMERCIAL RHODIOLA ROSEA PRODUCTS
    Thu, Ole Kristian F.
    Hellum, Bent H.
    Nilsen, Odd Georg
    DRUG METABOLISM REVIEWS, 2014, 45 : 134 - 135
  • [27] Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6
    Pandit, Subrata
    Mukherjee, Pulok K.
    Ponnusankar, Sivasankaran
    Venkatesh, Murugan
    Srikanth, N.
    FITOTERAPIA, 2011, 82 (03) : 369 - 374
  • [28] CHRONIC MODULATION OF CYP2D6 AND CYP3A4 ACTIVITIES BY QUINIDINE AND RIFAMPICIN RESPECTIVELY
    ADEDOYIN, A
    MAURO, K
    KUBISTY, C
    BOYER, A
    PORTER, J
    BRANCH, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 210 - 210
  • [29] Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin
    Al-Jenoobi, Fahad I.
    Al-Thukair, Areej A.
    Alam, Mohd Aftab
    Abbas, Fawkeya A.
    Al-Mohizea, Abdullah M.
    Alkharfy, Khalid M.
    Al-Suwayeh, Saleh A.
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (06) : 564 - 569
  • [30] Development and Validation of HPLC Methods for the Determination of CYP2D6 and CYP3A4 Activities
    Pan, Yan
    Mak, Joon Wah
    Ong, Chin Eng
    CURRENT PHARMACEUTICAL ANALYSIS, 2012, 8 (03) : 219 - 224
12345